Literature DB >> 25307426

Hyperactivation of BDNF-TrkB signaling cascades in human hypothalamic hamartoma (HH): a potential mechanism contributing to epileptogenesis.

Suzan Semaan1, Jie Wu, Yan Gan, Yu Jin, Guo-Hui Li, John F Kerrigan, Yong-Chang Chang, Yao Huang.   

Abstract

AIMS: Although compelling evidence suggests that human hypothalamic hamartoma (HH) is intrinsically epileptogenic for gelastic seizures, the molecular mechanisms responsible for epileptogenesis within HH remain to be elucidated. The aim of this study was to test the hypothesis that hyperactivation of BDNF-TrkB signaling pathways in surgically resected HH tissue is a possible mechanism for downregulation of KCC2 expression, which in turn underlies GABA-mediated excitation within HH.
METHODS: Activation of three major BDNF-TrkB signaling pathways including MAPKs, Akt, and PLCγ1 were evaluated in surgically resected HH tissue (n = 14) versus human hypothalamic control tissue (n = 8) using combined methodologies of biochemistry, molecular biology, cell biology, and electrophysiology.
RESULTS: Our data show that compared with hypothalamic control tissue, in HH tissue, (i) activation of TrkB and expression of mature BDNF are elevated; (ii) MAPKs (including ERK1/2, p38, and JNK), Akt, and PLCγ1 are highly activated; (iii) KCC2 expression is downregulated; and (iv) pharmacological manipulation of TrkB signaling alters HH neuronal firing rate.
CONCLUSION: Our findings suggest that multiple BDNF-TrkB signaling pathways are activated in HH. They act independently or collaboratively to downregulate KCC2 expression, which is the key component for GABA-mediated excitation associated with gelastic seizures.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Epileptogenesis; Human hypothalamic hamartoma; Signal transduction; Tropomysin-related kinase B

Mesh:

Substances:

Year:  2014        PMID: 25307426      PMCID: PMC6495156          DOI: 10.1111/cns.12331

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  5 in total

1.  Compromising KCC2 transporter activity enhances the development of continuous seizure activity.

Authors:  Matthew R Kelley; Tarek Z Deeb; Nicholas J Brandon; John Dunlop; Paul A Davies; Stephen J Moss
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

2.  Acute TrkB inhibition rescues phenobarbital-resistant seizures in a mouse model of neonatal ischemia.

Authors:  S K Kang; M V Johnston; S D Kadam
Journal:  Eur J Neurosci       Date:  2015-11       Impact factor: 3.386

3.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

4.  Effect of dexmedetomidine on hippocampal neuron development and BDNF-TrkB signal expression in neonatal rats.

Authors:  Jie Lv; Wei Ou; Xiao-Hua Zou; Yin Yao; Jin-Li Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-09       Impact factor: 2.570

5.  Salidroside Reduces High-Glucose-Induced Podocyte Apoptosis and Oxidative Stress via Upregulating Heme Oxygenase-1 (HO-1) Expression.

Authors:  Hua Lu; Ying Li; Tao Zhang; Maodong Liu; Yanqing Chi; Shuxia Liu; Yonghong Shi
Journal:  Med Sci Monit       Date:  2017-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.